AMIT G. PANDYA, MD
Advances in Treatment of Vitiligo With JAK Inhibitors
Meri K. Tulic, PhD
Analysis of Matched Skin and Gut Microbiome of Vitiligo Patients Reveals Dysbiosis in Lesional Skin: Association with Mitochondrial Damage and Changes in Immune Function
Victor Huang, MD
An Open-Label Pilot Study of Abatacept (CTLA4-Ig) for the Treatment of Nonsegmental Vitiligo
Iltefat H. Hamzavi, MD, FAAD Oral Abstract
Analysis of 24-Week Response to Ruxolitinib Cream for the Treatment of Vitiligo Based on Patient Demographics and Clinical Characteristics
Nanja van Geel, MD, PhD
International Collaborative Project to Standardize the Assessment and Monitoring of Vitiligo in Clinical Trials, Registries and Clinical Practice
